News updates
The I’M WOMAN Trial assess the benefits of intramuscular TXA in Tanzania
During the trip, the team saw first-hand the speed of an intramuscular (IM) injection, compared to TXA administered intravenously (IV). Read more.
16 pledges from I’M WOMAN Trial clinicians in Tanzania
In October, the I’M WOMAN Trial team exchanged knowledge in Tanzania on the benefits of tranexamic acid (TXA) for severe bleeding in women after childbirth, to prevent maternal deaths. Read more.
Tranexamic acid cuts life-threatening bleeding after birth, but anaemia prevention is critical, studies show
Two papers from the WOMAN Trials Collaborators, published in The Lancet today, reveal important evidence on the effects of the drug tranexamic acid (TXA) on postpartum haemorrhage (PPH) and life-threatening bleeding after childbirth. Read more.
Looking ahead: What next for WHO’s roadmap to fight PPH and WOMAN Trials research to reduce maternal deaths
A year ago today, the WHO released its first roadmap to combat deaths from postpartum haemorrhage (PPH) – a condition which affects millions of women every year around the world and kills tens of thousands. Read more.
